Medtronic PLC Current Financial Leverage
| MDT Stock | USD 79.19 0.11 0.14% |
Medtronic PLC holds a debt-to-equity ratio of 0.511. At this time, Medtronic PLC's Short and Long Term Debt Total is comparatively stable compared to the past year. Net Debt is likely to gain to about 27.6 B in 2024, whereas Long Term Debt Total is likely to drop slightly above 20.6 B in 2024. Medtronic PLC's financial risk is the risk to Medtronic PLC stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Medtronic PLC's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Medtronic PLC's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Medtronic Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Medtronic PLC's stakeholders.
For most companies, including Medtronic PLC, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for the executing running Medtronic PLC the most critical issue when dealing with liquidity needs is whether the current assets are properly aligned with its current liabilities. If not, management will need to obtain alternative financing to ensure that there are always enough cash equivalents on the balance sheet in reserve to pay for obligations.
Price Book 2.0543 | Book Value 38.952 | Operating Margin 0.1917 | Profit Margin 0.13 | Return On Assets 0.0423 |
Medtronic |
Medtronic PLC Financial Leverage Rating
Medtronic PLC bond ratings play a critical role in determining how much Medtronic PLC have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Medtronic PLC's borrowing costs.| Piotroski F Score | 5 Healthy |
| Beneish M Score | -2.27 Unlikely Manipulator |
Medtronic PLC Debt to Cash Allocation
As Medtronic PLC follows its natural business cycle, the capital allocation decisions will not magically go away. Medtronic PLC's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors. Many companies eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
The company has 24.36 B in debt with debt to equity (D/E) ratio of 0.51, which is OK given its current industry classification. Medtronic PLC has a current ratio of 1.72, which is typical for the industry and considered as normal. Debt can assist Medtronic PLC until it has trouble settling it off, either with new capital or with free cash flow. So, Medtronic PLC's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medtronic PLC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medtronic to invest in growth at high rates of return. When we think about Medtronic PLC's use of debt, we should always consider it together with cash and equity.Medtronic PLC Total Assets Over Time
Medtronic PLC Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Medtronic PLC's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Medtronic PLC, which in turn will lower the firm's financial flexibility. Like all other financial ratios, a a Medtronic PLC debt ratio should be compared their industry average or other competing firms.Medtronic Short Long Term Debt Total
Short Long Term Debt Total |
|
Understaning Medtronic PLC Use of Financial Leverage
Medtronic PLC financial leverage ratio helps in determining the effect of debt on the overall profitability of the company. It measures Medtronic PLC's total debt position, including all of outstanding debt obligations, and compares it with the equity. In simple terms, the high financial leverage means the cost of production, together with running the business day-to-day, is high, whereas, lower financial leverage implies lower fixed cost investment in the business and generally considered by investors to be a good sign. So if creditors own a majority of Medtronic PLC assets, the company is considered highly leveraged. Understanding the composition and structure of overall Medtronic PLC debt and outstanding corporate bonds gives a good idea of how risky the capital structure of a business and if it is worth investing in it. Financial leverage can amplify the potential profits to Medtronic PLC's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Medtronic PLC's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets).
| Last Reported | Projected for Next Year | ||
| Short and Long Term Debt Total | 28 B | 29.4 B | |
| Net Debt | 26.2 B | 27.6 B | |
| Short Term Debt | 23 M | 21.9 M | |
| Long Term Debt | 28 B | 29.4 B | |
| Short and Long Term Debt | 18 M | 17.1 M | |
| Long Term Debt Total | 21.9 B | 20.6 B | |
| Net Debt To EBITDA | 2.87 | 3.02 | |
| Debt To Equity | 0.51 | 0.28 | |
| Interest Debt Per Share | 20.31 | 21.32 | |
| Debt To Assets | 0.28 | 0.15 | |
| Long Term Debt To Capitalization | 0.34 | 0.36 | |
| Total Debt To Capitalization | 0.34 | 0.18 | |
| Debt Equity Ratio | 0.51 | 0.28 | |
| Debt Ratio | 0.28 | 0.15 | |
| Cash Flow To Debt Ratio | 0.24 | 0.22 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Medtronic PLC Fundamentals Over Time. For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.Note that the Medtronic PLC information on this page should be used as a complementary analysis to other Medtronic PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Medtronic Stock analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Medtronic PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medtronic PLC. If investors know Medtronic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medtronic PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.078 | Dividend Share 2.75 | Earnings Share 3.15 | Revenue Per Share 24.298 | Quarterly Revenue Growth 0.047 |
The market value of Medtronic PLC is measured differently than its book value, which is the value of Medtronic that is recorded on the company's balance sheet. Investors also form their own opinion of Medtronic PLC's value that differs from its market value or its book value, called intrinsic value, which is Medtronic PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medtronic PLC's market value can be influenced by many factors that don't directly affect Medtronic PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medtronic PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medtronic PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medtronic PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.